GoHealth Stock Forecast, Price & News

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GoHealth in the last year. There are currently 2 sell ratings, 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" GoHealth stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GOCO, but not buy additional shares or sell existing shares.
View analyst ratings for GoHealth or view top-rated stocks.

9 Wall Street research analysts have issued 1-year target prices for GoHealth's stock. Their GOCO stock forecasts range from $1.50 to $5.50. On average, they anticipate GoHealth's share price to reach $3.04 in the next twelve months. This suggests a possible upside of 408.8% from the stock's current price.
View analysts' price targets for GoHealth or view top-rated stocks among Wall Street analysts.

GoHealth's stock was trading at $3.79 at the beginning of the year. Since then, GOCO stock has decreased by 84.3% and is now trading at $0.5966.
View the best growth stocks for 2022 here.

GoHealth is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022.
View our earnings forecast for GoHealth.

GoHealth, Inc. (NASDAQ:GOCO) announced its earnings results on Tuesday, May, 10th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.09) by $0.03. The firm had revenue of $270.59 million for the quarter, compared to analyst estimates of $165.57 million. GoHealth had a positive trailing twelve-month return on equity of 10.28% and a negative net margin of 17.78%.
View GoHealth's earnings history.

GoHealth updated its FY 2022 earnings guidance on Tuesday, June, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $900.00M-$1.10 billion, compared to the consensus revenue estimate of $993.51 million.

25 employees have rated GoHealth CEO Matthew Crummack on Glassdoor.com. Matthew Crummack has an approval rating of 90% among GoHealth's employees.

Some companies that are related to GoHealth include SelectQuote (SLQT), eHealth (EHTH), Fanhua (FANH), Huize (HUIZ), Marketing Alliance (MAAL), Tian Ruixiang (TIRX), QDM International (QDMI), Arista Investors (ARINA), UMC (UMCN), AA (AATDF) and Patriot National (PNTPQ).
View all of GOCO's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other GoHealth investors own include Tesla (TSLA), Alibaba Group (BABA), CVS Health (CVS), (HON), Moderna (MRNA), Raytheon Technologies (RTX), Walmart (WMT), Cisco Systems (CSCO), Intel (INTC) and Johnson & Johnson (JNJ).

(GOCO) raised $750 million in an initial public offering on Wednesday, July 15th 2020. The company issued 39,500,000 shares at $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers.

GoHealth trades on the NASDAQ under the ticker symbol "GOCO."

GoHealth's stock is owned by a number of institutional and retail investors. Top institutional shareholders include First Trust Advisors LP (1.60%), Vanguard Group Inc. (1.45%), BlackRock Inc. (1.02%), Renaissance Technologies LLC (0.77%), State Street Corp (0.34%) and Healthcare of Ontario Pension Plan Trust Fund (0.34%). Company insiders that own GoHealth stock include Anita Pramoda, Brandon M Cruz, Clinton P Jones, Clinton P Jones, Nvx Holdings, Inc, Shane E Cruz and Travis J Matthiesen.
View institutional ownership trends for GoHealth.

GOCO stock was sold by a variety of institutional investors in the last quarter, including Glendon Capital Management LP, Vanguard Group Inc., Raymond James & Associates, Birch Grove Capital LP, Invesco Ltd., Daiwa Securities Group Inc., Assenagon Asset Management S.A., and Rothschild Investment Corp IL. Company insiders that have sold GoHealth company stock in the last two years include Shane E Cruz, and Travis J Matthiesen.
View insider buying and selling activity for GoHealth or view top insider-selling stocks.

GOCO stock was bought by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Renaissance Technologies LLC, Healthcare of Ontario Pension Plan Trust Fund, BlackRock Inc., Goldman Sachs Group Inc., Bank of America Corp DE, Oak Thistle LLC, and State Street Corp. Company insiders that have bought GoHealth stock in the last two years include Anita Pramoda, Brandon M Cruz, Clinton P Jones, and Nvx Holdings, Inc.
View insider buying and selling activity for GoHealth or or view top insider-buying stocks.

Shares of GOCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GOCO stock can currently be purchased for approximately $0.60.

GoHealth (NASDAQ:GOCO) has a market capitalization of $191.51 million and generates $1.06 billion in revenue each year. The company earns $-189.36 million in net income (profit) each year or ($1.770010) on an earnings per share basis.

GoHealth employs 5,448 workers across the globe.

GoHealth's mailing address is 214 WEST HURON STREET, CHICAGO IL, 60654. The official website for GoHealth is www.gohealth.com. The company can be reached via phone at 312-386-8200 or via email at [email protected].